Clinicopathological and prognostic relevance of uptake level using 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging (18F …
…, H Tsuda, H Asakawa, T Shigekawa… - Japanese journal of …, 2008 - academic.oup.com
Objective Using integrated 18 F-fluorodeoxyglucose positron emission tomography/computed
tomography fusion imaging ( 18 F-FDG PET/CT), the clinical significance of 18 F-FDG …
tomography fusion imaging ( 18 F-FDG PET/CT), the clinical significance of 18 F-FDG …
[HTML][HTML] In vivo imaging of eribulin-induced reoxygenation in advanced breast cancer patients: a comparison to bevacizumab
S Ueda, T Saeki, H Takeuchi, T Shigekawa… - British journal of …, 2016 - nature.com
Background: Eribulin mesylate (eribulin) is a first-in-class halichondrin B-based microtubule
dynamics inhibitor. To compare the anti-angiogenic activity of eribulin to that of bevacizumab…
dynamics inhibitor. To compare the anti-angiogenic activity of eribulin to that of bevacizumab…
[HTML][HTML] miR-378a-3p modulates tamoxifen sensitivity in breast cancer MCF-7 cells through targeting GOLT1A
…, T Ueno, T Suzuki, W Sato, T Shigekawa… - Scientific reports, 2015 - nature.com
Breast cancer is a hormone-dependent cancer and usually treated with endocrine therapy
using aromatase inhibitors or anti-estrogens such as tamoxifen. A majority of breast cancer, …
using aromatase inhibitors or anti-estrogens such as tamoxifen. A majority of breast cancer, …
Estrogen-related receptor γ modulates cell proliferation and estrogen signaling in breast cancer
N Ijichi, T Shigekawa, K Ikeda, K Horie-Inoue… - The Journal of steroid …, 2011 - Elsevier
Breast cancer is primarily a hormone-dependent tumor that can be regulated by status of
steroid hormones including estrogen and progesterone. Estrogen-related receptors (ERRs) are …
steroid hormones including estrogen and progesterone. Estrogen-related receptors (ERRs) are …
[HTML][HTML] FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with …
T Shigekawa, N Ijichi, K Ikeda, K Horie-Inoue… - Hormones and …, 2011 - Springer
Breast cancer is primarily a hormone-dependent tumor that can be regulated by the status
of steroid hormones, including estrogen and progesterone. Forkhead box P1 (FOXP1) is a …
of steroid hormones, including estrogen and progesterone. Forkhead box P1 (FOXP1) is a …
[HTML][HTML] Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review
…, Y Tanabe, N Tamura, Y Miura, T Shigekawa… - BMC cancer, 2019 - Springer
Background While denosumab has been shown to prevent skeletal-related events in
patients with bone metastasis, there is a concern that it may cause atypical femoral fracture (AFF). …
patients with bone metastasis, there is a concern that it may cause atypical femoral fracture (AFF). …
Squamous cell carcinoma of the breast in the form of an intracystic tumor
T Shigekawa, H Tsuda, K Sato, S Ueda, H Asakawa… - Breast cancer, 2007 - Springer
Squamous cell carcinoma of the breast is thought to arise through metaplasia of ductal
carcinoma cells. We report a case of pure squamous cell carcinoma of the breast with features of …
carcinoma cells. We report a case of pure squamous cell carcinoma of the breast with features of …
Early metabolic response to neoadjuvant letrozole, measured by FDG PET/CT, is correlated with a decrease in the Ki67 labeling index in patients with hormone …
…, H Tsuda, T Saeki, J Omata, A Osaki, T Shigekawa… - Breast Cancer, 2011 - Springer
Purpose To assess whether the early metabolic response evaluated by 18 F-fluorodeoxy-glucose
positron emission combined with computed tomography (FDG PET/CT) predicts the …
positron emission combined with computed tomography (FDG PET/CT) predicts the …
[HTML][HTML] Association of double-positive FOXA1 and FOXP1 immunoreactivities with favorable prognosis of tamoxifen-treated breast cancer patients
N Ijichi, T Shigekawa, K Ikeda, K Horie-Inoue… - Hormones and …, 2012 - Springer
Breast cancer is primarily a hormone-dependent tumor that can be regulated by the status of
the steroid hormones estrogen and progesterone. Forkhead box A1 (FOXA1) is a member …
the steroid hormones estrogen and progesterone. Forkhead box A1 (FOXA1) is a member …
Patritumab plus trastuzumab and paclitaxel in human epidermal growth factor receptor 2‐overexpressing metastatic breast cancer
…, K Aogi, Y Naito, N Matsubara, T Shigekawa… - Cancer …, 2016 - Wiley Online Library
Human epidermal growth factor receptor 3 ( HER 3) expression in lung and breast cancers
has a negative impact on survival. Patritumab, a human anti‐ HER 3 m A b, has shown …
has a negative impact on survival. Patritumab, a human anti‐ HER 3 m A b, has shown …